Development of a computational Management system of hemodynamics in patients with acute myocardial infarction
急性心肌梗死患者血流动力学计算管理系统的开发
基本信息
- 批准号:18500358
- 负责人:
- 金额:$ 2.36万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have developed a novel automated drug delivery system for simultaneous control of systemic arterial pressue(AP) , cardiac output(CO) , and left atrial pressure(P_<LA>) . With this system, hemodynamics of heart failure patients after acute myocardial infarction can be automatically restored to normal condition. We further expanded our system so that the system can optimize cardiac oxygen metabolism as well as hemodynamics in such patients through precise control of heart rate reduction and ventricular inotropy. In a canine acute heart failure model, the expanded system was able to improve cardiac oxygen metabolism while restoring normal hemodynamic condition. Whether the improvement in cardiac oxygen metabolism as achieved by our system really ameliorates the myocardial damage remained to be evaluated. To answer this question, we developed an artificial arterial preparation, to which an isolated rabbit heart is connected. The preparation enables us to continuously monitor the oxygen metabolism of the rabbit heart while AP, CO, and P_<LA> are simultaneously controlled to a desired level.Electrical stimulation of vagal nerve can be an efficient method of heart rate reduction in our system. In a rabbit model of myocardial ischemia-reperfusion injury, we investigated the effects of electrical stimulation of efferent vagal nerve on myocaidial expression and activation of Cardiac Matrix Metalloproteinase, which is known to play crucial roles in the progression of heart failure after acute myocardial infarction. We disclosed that stimulation of the efferent vagal nerve increased mRNA and protein level of endogenous inhibitor of Cardiac Matrix Metalloproteinase(TIMP-1) , and reduced activity of Cardiac Matrix Metalloproteinase. This means that vagal stimulation can be not only an effective method of heart rate reduction, but also an effective method of cardio protection in acute heart failure.
我们研制了一种能同时控制体循环动脉压(AP)、心输出量(CO)和左心房压(P_2)的新型自动给药系统<LA>。该系统可自动使急性心肌梗死后心力衰竭患者的血流动力学恢复正常。我们进一步扩展了我们的系统,使该系统可以通过精确控制心率降低和心室收缩力来优化心脏氧代谢以及此类患者的血液动力学。在犬急性心力衰竭模型中,扩张系统能够改善心脏氧代谢,同时恢复正常的血流动力学状态。我们的系统所实现的心脏氧代谢的改善是否真的改善了心肌损伤仍有待评估。为了回答这个问题,我们开发了一种人工动脉制剂,将离体兔心脏连接到该制剂上。该制剂能连续监测家兔心脏氧代谢,同时将AP、CO和<LA>P_2控制在所需水平,电刺激迷走神经可有效降低心率。在兔心肌缺血再灌注损伤模型中,我们研究了电刺激迷走神经对心肌基质金属蛋白酶表达和激活的影响,该蛋白酶在急性心肌梗死后心力衰竭的进展中起着至关重要的作用。我们发现,刺激迷走神经的传出增加心脏基质金属蛋白酶的内源性抑制剂(TIMP-1)的mRNA和蛋白水平,并降低心脏基质金属蛋白酶的活性。这意味着迷走神经刺激不仅是降低心率的有效方法,而且是急性心力衰竭的有效心脏保护方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit
- DOI:10.1152/ajpheart.00490.2007
- 发表时间:2007-10-01
- 期刊:
- 影响因子:4.8
- 作者:Uemura, Kazunori;Li, Meihua;Sugimachi, Masaru
- 通讯作者:Sugimachi, Masaru
Novel technique to monitor cardiac output by measuring left pulmonary impedance, potentially applicable to patients with a cardiac resynchronization/defibrillation device.
通过测量左肺阻抗来监测心输出量的新技术,可能适用于带有心脏再同步/除颤装置的患者。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Uemura K;Inagaki M;Sugimachi M.
- 通讯作者:Sugimachi M.
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
自动给药系统可控制急性失代偿性心力衰竭的全身动脉压、心输出量和左心充盈压。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:T.Ito et al.;M.Kawashita.et al.;Y.Jujimura;Kazuhiro NAKASHIMA et al.;Uemura K et al.
- 通讯作者:Uemura K et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UEMURA Kazunori其他文献
UEMURA Kazunori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UEMURA Kazunori', 18)}}的其他基金
Development of minimally invasive monitor of left atrial pressure, and its application to computer-controlled hemodynamic management system
微创左心房压力监测仪的研制及其在计算机控制血流动力学管理系统中的应用
- 批准号:
24500565 - 财政年份:2012
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of vagal nerve stimulation therapy by computational management of hemodynamics in acute myocardial infarction
通过计算管理急性心肌梗死的血流动力学开发迷走神经刺激疗法
- 批准号:
20500404 - 财政年份:2008
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Alterations in macrophage metabolism in heart failure with preserved ejection
射血保留性心力衰竭患者巨噬细胞代谢的改变
- 批准号:
502586 - 财政年份:2024
- 资助金额:
$ 2.36万 - 项目类别:
SBIR Phase II: In-vivo validation of a volume-manufacturable and factory-calibrated wearable NT-proBNP monitoring system for heart failure treatment
SBIR II 期:用于心力衰竭治疗的可批量生产和工厂校准的可穿戴 NT-proBNP 监测系统的体内验证
- 批准号:
2335105 - 财政年份:2024
- 资助金额:
$ 2.36万 - 项目类别:
Cooperative Agreement
RAPHAEL - Integrating a Palliative Care Approach for Patients with Heart Failure
RAPHAEL - 为心力衰竭患者整合姑息治疗方法
- 批准号:
10112701 - 财政年份:2024
- 资助金额:
$ 2.36万 - 项目类别:
EU-Funded
Exploratory research to elucidate the molecular mechanisms by which depression makes heart failure more severe and to reconstruct heart failure treatment strategies.
探索性研究旨在阐明抑郁症使心力衰竭更加严重的分子机制,并重建心力衰竭治疗策略。
- 批准号:
23K07507 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
- 批准号:
491149 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Fellowship Programs
Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization
机器学习与传统统计模型预测急性心力衰竭住院后再入院的比较
- 批准号:
495410 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Elucidation of the precise mechanism of heart failure prevention by beta-catenin inhibition enabling the future development of a novel class of medicine
阐明β-连环蛋白抑制预防心力衰竭的精确机制,有助于未来开发一类新型药物
- 批准号:
23K15167 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel ventricular arrhythmias mechanism in ischemic heart failure focusing on neuropeptide Y
以神经肽Y为重点的缺血性心力衰竭室性心律失常新机制
- 批准号:
23K15119 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel pathophysiology and development of treatment for heart failure using human iPS cell-derived 3D heart tissue
利用人 iPS 细胞衍生的 3D 心脏组织阐明新的病理生理学并开发心力衰竭治疗方法
- 批准号:
23K15140 - 财政年份:2023
- 资助金额:
$ 2.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




